Kingworld Medicines Group Limited (1110.HK)
HKSE · HKD · Healthcare · Pharmaceutical Retailers
HK$0.385 (-1.28%) as of
Key statistics
- Market cap
- 228.10M
- P/E (TTM)
- 19.25
- Forward P/E
- 2.75
- EPS (TTM)
- 0.020
- Dividend yield
- 0.00%
- 52-week range
- 0.330 – 0.780
- Beta
- 0.87
- Revenue (TTM)
- 787.87M
- Profit margin
- 1.46%
- Volume
- 1.10M
About Kingworld Medicines Group Limited
Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution, manufacture, and sale of branded imported pharmaceutical and healthcare products. The company offers products for relieving cough, alleviating phlegm, soothing asthma, enhancing respiratory system, aiding digestion, promoting intestinal health, activating blood circulation, relieving pain, combating flu, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, and Kingworld Imada Red Flower Oil brands. It also manufactures and sells electrotherapeutic and physiotherapeutic devices, and general medical examination devices; and supplies pharmaceuticals, healthcare, general foodstuffs, and medical products. In addition, the company is involved in the distribution and sale of artwork; organization of art exhibitions; distribution and sale of Chinese medicine; and engages in technology transfer and property investment activities. It operates in the People's Republic of China, France, the United States, Hong Kong, the United Kingdom, Germany, Italy, Spain, Mexico, and internationally. The company was founded in 1996 and is headquartered in Shenzhen, the People's Republic of China.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Headquarters
- Shenzhen, China
- Employees
- 711
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.